Table 5.
Changes in blood factors.
| Intervention group | Control group | P-value | |||||
|---|---|---|---|---|---|---|---|
| Pre-program | Post-program | Change | Pre-program | Post-program | Change | ||
| TG (mg/dL) | 79.3±40.3 | 52.8±13.0 | −26.5±29.2# | 76.7±36.3 | 84.7±35.9 | 8.0±27.9 | 0.003 |
| TC (mg/dL) | 171.3±38.0 | 157.8±25.7 | −13.5±17.8# | 181.1±23.9 | 180.6±25.7 | −0.5±14.2 | 0.037 |
| HDL-C (mg/dL) | 96.4±31.8 | 80.8±21.9 | −15.6±15.2 | 104.6±24.4 | 102.9±25.6 | −1.7±11.6 | 0.289 |
| LDL-C (mg/dL) | 64.9±12.7 | 66.4±13.0 | 1.4±5.7# | 66.4±12.7 | 65.3±9.4 | −1.1±7.4 | 0.010 |
| Glucose (mg/dL) | 90.9±8.0 | 84.4±8.8 | −6.5±6.8# | 87.1±5.4 | 90.0±6.3 | 2.9±3.7* | <0.001 |
| Insulin (μIU/mL) | 8.8±8.6 | 4.3±2.4 | −4.5±8.5 | 8.3±3.6 | 8.2±3.5 | −0.1±2.7 | 0.075 |
| HOMA-IR | 2.0±2.0 | 0.9±0.6 | −1.1±1.9* | 1.8±0.8 | 1.8±0.8 | 0.0±0.6 | 0.047 |
*
P<0.05;
#
P<0.01;
&
P<0.001 calculated from the Wilcoxon signed ranks test.
TG – triglyceride; TC – total cholesterol; HDL-C – high-density lipoprotein cholesterol; LDL-C – low-density lipoprotein cholesterol: HOMA-IR – homeostatic model assessment of insulin resistance.